How much funding has OssiFi raised?

OssiFi has disclosed $2M raised across 3 rounds.

Where is OssiFi headquartered?

OssiFi is headquartered in Overland Park, US.

OssiFi

Overland Park, US · Delaware corporation

Find your way into OssiFi

158 people in our graph share verified history with the OssiFi team — schools, employers, funds. One of them is your warm intro.

Reid Leonardunlockedknows Debra L Ellies · together at OssiFi (overlapped)

×11knows the team · via University of Ottawa

OssiFi develops small molecule therapeutics targeting bone growth modulation, specifically focusing on inhibiting Wnt pathway regulators to treat conditions like osteoporosis. The company leverages established drug development technologies and manufacturing expertise to advance candidates through clinical development.

Biotech Medical Devices

Founders & leadership

Debra L Ellies Chief Executive OfficerDebra L Ellies is Executive Officer at OssiFi, where she has led bone regenerative medicine research for over 18 years, including work on sclerostin-blocking therapeutics. She holds expertise in molecular embryology and anatomy, serves as a trustee at MRIGlobal, and has contributed to the development of therapies targeting bone-related conditions.

Board

Frank LoefflerBoard director

Kelly DrouillardBoard director

Reported raises · per SEC filings

Form D private placements

$2M disclosed across 3 rounds · 2016–2018

▶$1.5MraisedNov 2018 · 17 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Debra L ElliesExecutive Officer

Offering amount: $1.5M
Amount sold: $1.5M
Minimum investment: $50K
Proceeds to insiders: $90K
First sale: Oct 2018
Incorporated: Corporation, Delaware
Federal exemptions: 04, 06b, 4a5

Full filing on SEC EDGAR ↗

▶$361KraisedApr 2017 · 15 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Debra L ElliesExecutive Officer, Director
Kelly DrouillardDirector
Frank LoefflerDirector

Amount sold: $361K
Minimum investment: $50K
Proceeds to insiders: $64.6K
First sale: Mar 2017
Incorporated: Corporation, Delaware
Federal exemptions: 04, 06b, 4a5

Full filing on SEC EDGAR ↗

▶$96.4KraisedSep 2016 · 4 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Frank LoefflerDirector
Kelly DrouillardDirector
Debra L ElliesExecutive Officer

Offering amount: $400K
Amount sold: $96.4K
Minimum investment: $50K
Proceeds to insiders: $60K
First sale: Sep 2016
Incorporated: Corporation, Delaware
Federal exemptions: 04, 06b, 4a5

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

SoundCloud3 shared keywordsAudio distribution and music-sharing platform for artists and creators.

Companies competing with OssiFi for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does OssiFi do?: OssiFi develops small molecule therapeutics targeting bone growth modulation, specifically focusing on inhibiting Wnt pathway regulators to treat conditions like osteoporosis. The company leverages established drug development technologies and manufacturing expertise to advance candidates through clinical development.
How much funding has OssiFi raised?: OssiFi has disclosed $2M raised across 3 rounds.
Where is OssiFi headquartered?: OssiFi is headquartered in Overland Park, US.